Source: Global Legal Chronicle

Cardurion: Cardurion Pharmaceuticals' $300 Million Investment

Mintz advised Cardurion Pharmaceuticals on the deal. Cardurion Pharmaceuticals, Inc. (Cardurion), a clinical-stage biotechnology company, announced a private investment of up to $300 million from Bain Capital [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Peter S. Lawrence's photo - President & CEO of Cardurion

President & CEO

Peter S. Lawrence

CEO Approval Rating

88/100

Read more